Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bhumyamalaki, botanically known as *Phyllanthus niruri* or *Phyllanthus amarus*, is a tropical herb widely utilized in Ayurvedic medicine for its potent hepatoprotective and antiviral properties. It is most notably recognized for its ability to treat liver disorders, including chronic Hepatitis B, by inhibiting the viral DNA polymerase and preventing viral replication. Additionally, the herb is frequently referred to as stonebreaker due to its lithontriptic activity, which helps in the dissolution and passage of renal calculi (kidney stones) by interfering with the crystallization and aggregation of calcium oxalate. Its pharmacological profile is attributed to bioactive lignans such as phyllanthin and hypophyllanthin, which exhibit significant antioxidant and anti-inflammatory effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bhumyamalaki.